{"id":11226,"date":"2018-08-23T01:48:11","date_gmt":"2018-08-23T01:48:11","guid":{"rendered":"https:\/\/magazines.uthscsa.edu\/mission-new\/?p=11226"},"modified":"2018-08-30T16:44:57","modified_gmt":"2018-08-30T16:44:57","slug":"changing-the-standard-of-cancer-care","status":"publish","type":"post","link":"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-standard-of-cancer-care\/","title":{"rendered":"Changing the standard of cancer care"},"content":{"rendered":"<p><img decoding=\"async\" class=\"alignright wp-image-11227\" src=\"https:\/\/magazines.uthscsa.edu\/mission\/wp-content\/uploads\/sites\/20\/2018\/08\/bladder.jpg\" alt=\"\" width=\"500\" height=\"652\" srcset=\"https:\/\/magazines.uthscsa.edu\/mission\/wp-content\/uploads\/sites\/20\/2018\/08\/bladder.jpg 630w, https:\/\/magazines.uthscsa.edu\/mission\/wp-content\/uploads\/sites\/20\/2018\/08\/bladder-115x150.jpg 115w, https:\/\/magazines.uthscsa.edu\/mission\/wp-content\/uploads\/sites\/20\/2018\/08\/bladder-230x300.jpg 230w\" sizes=\"(max-width: 500px) 100vw, 500px\" \/>Bladder cancer patients who received the chemotherapy drug gemcitabine had significantly lower recurrence of their cancer, a clinical trial has revealed.<\/p>\n<p>The multi-institution trial involved 406 patients with newly diagnosed bladder cancer or low-grade bladder cancer that had not invaded the muscle wall. Those who received gemcitabine-saline treatment directly into the bladder within three hours following surgery had an estimated recurrence rate of 36 percent within four years. There was a 48 percent recurrence rate in the same time frame for those receiving a saline-only treatment.<\/p>\n<p>\u201cThis is a huge difference in recurrence rate and demonstrated that gemcitabine is a safe and well-tolerated drug,\u201d said Robert Svatek, M.D., the university\u2019s study leader and a genitourinary oncologist. \u201cWe expect this study to change the standard of care.\u201d<\/p>\n<p>There were no significant side effects for patients in the study, and gemcitabine, which is already approved by the Food and Drug Administration to treat several types of cancer, is less expensive than many other therapies frequently used in the U.S.<span class=\"Apple-converted-space\">\u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bladder cancer patients who received the chemotherapy drug gemcitabine had significantly lower recurrence of their cancer, a clinical trial has revealed.<\/p>\n","protected":false},"author":47,"featured_media":11303,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[63,229],"tags":[116,212],"ppma_author":[281],"class_list":["post-11226","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-university-in-motion","category-summer-2018","tag-cancer","tag-clinical-trials"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Changing the standard of cancer care - Mission Magazine<\/title>\n<meta name=\"description\" content=\"Bladder cancer patients who received the chemotherapy drug gemcitabine had significantly lower recurrence of their cancer, a clinical trial has revealed.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-standard-of-cancer-care\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Changing the standard of cancer care - Mission Magazine\" \/>\n<meta property=\"og:description\" content=\"Bladder cancer patients who received the chemotherapy drug gemcitabine had significantly lower recurrence of their cancer, a clinical trial has revealed.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-standard-of-cancer-care\/\" \/>\n<meta property=\"og:site_name\" content=\"Mission Magazine\" \/>\n<meta property=\"article:published_time\" content=\"2018-08-23T01:48:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-08-30T16:44:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/magazines.uthscsa.edu\/mission\/wp-content\/uploads\/sites\/20\/2018\/08\/Svatek_DSC_046.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"668\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lety Laurel\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lety Laurel\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-standard-of-cancer-care\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-standard-of-cancer-care\/\"},\"author\":{\"name\":\"Lety Laurel\",\"@id\":\"https:\/\/magazines.uthscsa.edu\/mission\/#\/schema\/person\/d1325d64aa41023ee56656bc3858ae91\"},\"headline\":\"Changing the standard of cancer care\",\"datePublished\":\"2018-08-23T01:48:11+00:00\",\"dateModified\":\"2018-08-30T16:44:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-standard-of-cancer-care\/\"},\"wordCount\":173,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/magazines.uthscsa.edu\/mission\/#organization\"},\"image\":{\"@id\":\"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-standard-of-cancer-care\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/magazines.uthscsa.edu\/mission\/wp-content\/uploads\/sites\/20\/2018\/08\/Svatek_DSC_046.jpg\",\"keywords\":[\"cancer\",\"clinical trials\"],\"articleSection\":[\"University in Motion\",\"Summer 2018\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-standard-of-cancer-care\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-standard-of-cancer-care\/\",\"url\":\"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-standard-of-cancer-care\/\",\"name\":\"Changing the standard of cancer care - Mission Magazine\",\"isPartOf\":{\"@id\":\"https:\/\/magazines.uthscsa.edu\/mission\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-standard-of-cancer-care\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-standard-of-cancer-care\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/magazines.uthscsa.edu\/mission\/wp-content\/uploads\/sites\/20\/2018\/08\/Svatek_DSC_046.jpg\",\"datePublished\":\"2018-08-23T01:48:11+00:00\",\"dateModified\":\"2018-08-30T16:44:57+00:00\",\"description\":\"Bladder cancer patients who received the chemotherapy drug gemcitabine had significantly lower recurrence of their cancer, a clinical trial has revealed.\",\"breadcrumb\":{\"@id\":\"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-standard-of-cancer-care\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-standard-of-cancer-care\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-standard-of-cancer-care\/#primaryimage\",\"url\":\"https:\/\/magazines.uthscsa.edu\/mission\/wp-content\/uploads\/sites\/20\/2018\/08\/Svatek_DSC_046.jpg\",\"contentUrl\":\"https:\/\/magazines.uthscsa.edu\/mission\/wp-content\/uploads\/sites\/20\/2018\/08\/Svatek_DSC_046.jpg\",\"width\":1000,\"height\":668,\"caption\":\"Dr. Svatec looks through microscope\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-standard-of-cancer-care\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/magazines.uthscsa.edu\/mission\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Changing the standard of cancer care\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/magazines.uthscsa.edu\/mission\/#website\",\"url\":\"https:\/\/magazines.uthscsa.edu\/mission\/\",\"name\":\"Mission Magazine\",\"description\":\"The University of Texas Health Science Center at San Antonio Mission magazine\",\"publisher\":{\"@id\":\"https:\/\/magazines.uthscsa.edu\/mission\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/magazines.uthscsa.edu\/mission\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/magazines.uthscsa.edu\/mission\/#organization\",\"name\":\"Mission Magazine\",\"url\":\"https:\/\/magazines.uthscsa.edu\/mission\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/magazines.uthscsa.edu\/mission\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/magazines.uthscsa.edu\/mission\/wp-content\/uploads\/sites\/20\/2024\/10\/UTHSA_logo_H_CMYK-350.jpg\",\"contentUrl\":\"https:\/\/magazines.uthscsa.edu\/mission\/wp-content\/uploads\/sites\/20\/2024\/10\/UTHSA_logo_H_CMYK-350.jpg\",\"width\":350,\"height\":121,\"caption\":\"Mission Magazine\"},\"image\":{\"@id\":\"https:\/\/magazines.uthscsa.edu\/mission\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/magazines.uthscsa.edu\/mission\/#\/schema\/person\/d1325d64aa41023ee56656bc3858ae91\",\"name\":\"Lety Laurel\",\"url\":\"https:\/\/magazines.uthscsa.edu\/mission\/author\/laurell\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Changing the standard of cancer care - Mission Magazine","description":"Bladder cancer patients who received the chemotherapy drug gemcitabine had significantly lower recurrence of their cancer, a clinical trial has revealed.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-standard-of-cancer-care\/","og_locale":"en_US","og_type":"article","og_title":"Changing the standard of cancer care - Mission Magazine","og_description":"Bladder cancer patients who received the chemotherapy drug gemcitabine had significantly lower recurrence of their cancer, a clinical trial has revealed.","og_url":"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-standard-of-cancer-care\/","og_site_name":"Mission Magazine","article_published_time":"2018-08-23T01:48:11+00:00","article_modified_time":"2018-08-30T16:44:57+00:00","og_image":[{"width":1000,"height":668,"url":"https:\/\/magazines.uthscsa.edu\/mission\/wp-content\/uploads\/sites\/20\/2018\/08\/Svatek_DSC_046.jpg","type":"image\/jpeg"}],"author":"Lety Laurel","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Lety Laurel","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-standard-of-cancer-care\/#article","isPartOf":{"@id":"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-standard-of-cancer-care\/"},"author":{"name":"Lety Laurel","@id":"https:\/\/magazines.uthscsa.edu\/mission\/#\/schema\/person\/d1325d64aa41023ee56656bc3858ae91"},"headline":"Changing the standard of cancer care","datePublished":"2018-08-23T01:48:11+00:00","dateModified":"2018-08-30T16:44:57+00:00","mainEntityOfPage":{"@id":"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-standard-of-cancer-care\/"},"wordCount":173,"commentCount":0,"publisher":{"@id":"https:\/\/magazines.uthscsa.edu\/mission\/#organization"},"image":{"@id":"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-standard-of-cancer-care\/#primaryimage"},"thumbnailUrl":"https:\/\/magazines.uthscsa.edu\/mission\/wp-content\/uploads\/sites\/20\/2018\/08\/Svatek_DSC_046.jpg","keywords":["cancer","clinical trials"],"articleSection":["University in Motion","Summer 2018"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/magazines.uthscsa.edu\/mission\/changing-the-standard-of-cancer-care\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-standard-of-cancer-care\/","url":"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-standard-of-cancer-care\/","name":"Changing the standard of cancer care - Mission Magazine","isPartOf":{"@id":"https:\/\/magazines.uthscsa.edu\/mission\/#website"},"primaryImageOfPage":{"@id":"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-standard-of-cancer-care\/#primaryimage"},"image":{"@id":"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-standard-of-cancer-care\/#primaryimage"},"thumbnailUrl":"https:\/\/magazines.uthscsa.edu\/mission\/wp-content\/uploads\/sites\/20\/2018\/08\/Svatek_DSC_046.jpg","datePublished":"2018-08-23T01:48:11+00:00","dateModified":"2018-08-30T16:44:57+00:00","description":"Bladder cancer patients who received the chemotherapy drug gemcitabine had significantly lower recurrence of their cancer, a clinical trial has revealed.","breadcrumb":{"@id":"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-standard-of-cancer-care\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/magazines.uthscsa.edu\/mission\/changing-the-standard-of-cancer-care\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-standard-of-cancer-care\/#primaryimage","url":"https:\/\/magazines.uthscsa.edu\/mission\/wp-content\/uploads\/sites\/20\/2018\/08\/Svatek_DSC_046.jpg","contentUrl":"https:\/\/magazines.uthscsa.edu\/mission\/wp-content\/uploads\/sites\/20\/2018\/08\/Svatek_DSC_046.jpg","width":1000,"height":668,"caption":"Dr. Svatec looks through microscope"},{"@type":"BreadcrumbList","@id":"https:\/\/magazines.uthscsa.edu\/mission\/changing-the-standard-of-cancer-care\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/magazines.uthscsa.edu\/mission\/"},{"@type":"ListItem","position":2,"name":"Changing the standard of cancer care"}]},{"@type":"WebSite","@id":"https:\/\/magazines.uthscsa.edu\/mission\/#website","url":"https:\/\/magazines.uthscsa.edu\/mission\/","name":"Mission Magazine","description":"The University of Texas Health Science Center at San Antonio Mission magazine","publisher":{"@id":"https:\/\/magazines.uthscsa.edu\/mission\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/magazines.uthscsa.edu\/mission\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/magazines.uthscsa.edu\/mission\/#organization","name":"Mission Magazine","url":"https:\/\/magazines.uthscsa.edu\/mission\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/magazines.uthscsa.edu\/mission\/#\/schema\/logo\/image\/","url":"https:\/\/magazines.uthscsa.edu\/mission\/wp-content\/uploads\/sites\/20\/2024\/10\/UTHSA_logo_H_CMYK-350.jpg","contentUrl":"https:\/\/magazines.uthscsa.edu\/mission\/wp-content\/uploads\/sites\/20\/2024\/10\/UTHSA_logo_H_CMYK-350.jpg","width":350,"height":121,"caption":"Mission Magazine"},"image":{"@id":"https:\/\/magazines.uthscsa.edu\/mission\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/magazines.uthscsa.edu\/mission\/#\/schema\/person\/d1325d64aa41023ee56656bc3858ae91","name":"Lety Laurel","url":"https:\/\/magazines.uthscsa.edu\/mission\/author\/laurell\/"}]}},"authors":[{"term_id":281,"user_id":47,"is_guest":0,"slug":"laurell","display_name":"Lety Laurel","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/ac3c3dba33fe513a1eddbc04fa4c5a95cb98da9df39989cf39296c91957f4181?s=96&d=mm&r=g","0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/magazines.uthscsa.edu\/mission\/wp-json\/wp\/v2\/posts\/11226","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/magazines.uthscsa.edu\/mission\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/magazines.uthscsa.edu\/mission\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/magazines.uthscsa.edu\/mission\/wp-json\/wp\/v2\/users\/47"}],"replies":[{"embeddable":true,"href":"https:\/\/magazines.uthscsa.edu\/mission\/wp-json\/wp\/v2\/comments?post=11226"}],"version-history":[{"count":0,"href":"https:\/\/magazines.uthscsa.edu\/mission\/wp-json\/wp\/v2\/posts\/11226\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/magazines.uthscsa.edu\/mission\/wp-json\/wp\/v2\/media\/11303"}],"wp:attachment":[{"href":"https:\/\/magazines.uthscsa.edu\/mission\/wp-json\/wp\/v2\/media?parent=11226"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/magazines.uthscsa.edu\/mission\/wp-json\/wp\/v2\/categories?post=11226"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/magazines.uthscsa.edu\/mission\/wp-json\/wp\/v2\/tags?post=11226"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/magazines.uthscsa.edu\/mission\/wp-json\/wp\/v2\/ppma_author?post=11226"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}